Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

March 30, 2018

Study Completion Date

March 30, 2018

Conditions
Dementia
Interventions
BEHAVIORAL

West Wales Adverse Drug Reaction (WWADR) Profile

Nurse-led medicines' monitoring in care homes: a process evaluation of the impact and sustainability of the West Wales Adverse Drug Reaction (WWADR) Profile and pharmacist involvement

BEHAVIORAL

usual care

usual care

Trial Locations (10)

CF33 4PN

Llys Gywn Residential Home, Cardiff

CF36 3HU

Monkstone House, Cardiff

CF36 5SR

Danygraig House, Cardiff

SA10 6NR

Neuadddrymmau care home, Swansea

SA10 6YR

Cefnlodge Care Home, Swansea

SA12 7PH

Swn-y-mor care home, Swansea

SA18 1UF

Glangarnant care home, Swansea

SA79LA

Fieldbay Ltd, Swansea

SA3 2HQ

Three Cliffs Care Home, Swansea

SA79EN

Glais Care Home, Swansea

All Listed Sponsors
collaborator

Abertawe Bro Morgannwg University Health Board

OTHER

lead

Swansea University

OTHER

NCT03110471 - Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation | Biotech Hunter | Biotech Hunter